Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic

NCT01552395 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT01552395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01552395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
April 30, 2016
Enrollment
4,136 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

nocturia